ImmuCell Corporation (ICCC) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Morning and welcome to the INUSA Corporation Report 1st Quarter ended March 31st, 2025 Audited Financial Results Conference Call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference call over to Joe Diaz of Listen Partners. Please go ahead. Thank you, Vicki. Good morning and welcome to all. As the operator indicated, my name is Joe Diaz with Lithum Partners. We are the investor relations consulting firm for EmuCell. I thank all of you for joining us today to discuss the unaudited financial results for the first quarter ended March 31, 2025. Listeners are reminded and cautioned that statements made by management during the course of this call include forward-looking statements. which include any statement that refers to future events or expected future results or predictions about steps the company plans to take in the future. These statements are not guarantees of performance and are subject to risks and uncertainties that could cause actual results, outcomes, or events to differ materially from those discussed today. Additional information regarding forward-looking statements and the risks and uncertainties that could impact future results, outcomes, or advances available under the cautionary note regarding forward-looking statements or the safe harbor statement provided with Form 10-Q and the press release the company filed last night, along with the company's other periodic filings with the SEC. Information discussed on today's call speaks only as of today, Thursday, May 15, 2025. The company undertakes no obligation to update any information discussed on today's call. Please note that references to certain non-GAAP...